Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
ACS Chemical Biology
|
August 5, 2022
Characterization of a Nanobody-Epitope Tag Interaction and Its Application for Receptor Engineering
Chino C Cabalteja, Shivani Sachdev, Ross W Cheloha
Nature Communications
|
June 1, 2024
Highly biased agonism for GPCR ligands via nanobody tethering
Shivani Sachdev, Brendan A Creemer, Thomas J Gardella, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Highly biased agonism for GPCR ligands via nanobody tethering
Shivani Sachdev, Brendan A Creemer, Thomas J Gardella, et al.
Chemical Communications (Cambridge, England)
|
December 22, 2010
A new dehydrogenase from Clostridium acetobutylicum for asymmetric synthesis: dynamic reductive kinetic resolution entry into the Taxotère side chain
Gregory A Applegate, Ross W Cheloha, David L Nelson, et al.
RSC Chemical Biology
|
January 3, 2022
Activation of a G protein-coupled receptor through indirect antibody-mediated tethering of ligands
Ross W Cheloha, Fabian A Fischer, Thomas J Gardella, et al.
Nature Reviews. Endocrinology
|
August 26, 2015
PTH receptor-1 signalling-mechanistic insights and therapeutic prospects
Ross W Cheloha, Samuel H Gellman, Jean-Pierre Vilardaga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 17, 2018
Receptor selectivity from minimal backbone modification of a polypeptide agonist
Shi Liu, Ross W Cheloha, Tomoyuki Watanabe, et al.
Cell Chemical Biology
|
June 23, 2021
Activity-based, bioorthogonal imaging of phospholipase D reveals spatiotemporal dynamics of GPCR-Gq signaling
Dongjun Liang, Ross W Cheloha, Tomoyuki Watanabe, et al.
ACS Chemical Biology
|
August 18, 2016
Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist
Ross W Cheloha, Tomoyuki Watanabe, Thomas Dean, et al.
Nature Biotechnology
|
June 16, 2014
Backbone modification of a polypeptide drug alters duration of action in vivo
Ross W Cheloha, Akira Maeda, Thomas Dean, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
ACS Chemical Biology
|
August 5, 2022
Characterization of a Nanobody-Epitope Tag Interaction and Its Application for Receptor Engineering
Chino C Cabalteja, Shivani Sachdev, Ross W Cheloha
Nature Communications
|
June 1, 2024
Highly biased agonism for GPCR ligands via nanobody tethering
Shivani Sachdev, Brendan A Creemer, Thomas J Gardella, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Highly biased agonism for GPCR ligands via nanobody tethering
Shivani Sachdev, Brendan A Creemer, Thomas J Gardella, et al.
Chemical Communications (Cambridge, England)
|
December 22, 2010
A new dehydrogenase from Clostridium acetobutylicum for asymmetric synthesis: dynamic reductive kinetic resolution entry into the Taxotère side chain
Gregory A Applegate, Ross W Cheloha, David L Nelson, et al.
RSC Chemical Biology
|
January 3, 2022
Activation of a G protein-coupled receptor through indirect antibody-mediated tethering of ligands
Ross W Cheloha, Fabian A Fischer, Thomas J Gardella, et al.
Nature Reviews. Endocrinology
|
August 26, 2015
PTH receptor-1 signalling-mechanistic insights and therapeutic prospects
Ross W Cheloha, Samuel H Gellman, Jean-Pierre Vilardaga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 17, 2018
Receptor selectivity from minimal backbone modification of a polypeptide agonist
Shi Liu, Ross W Cheloha, Tomoyuki Watanabe, et al.
Cell Chemical Biology
|
June 23, 2021
Activity-based, bioorthogonal imaging of phospholipase D reveals spatiotemporal dynamics of GPCR-Gq signaling
Dongjun Liang, Ross W Cheloha, Tomoyuki Watanabe, et al.
ACS Chemical Biology
|
August 18, 2016
Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist
Ross W Cheloha, Tomoyuki Watanabe, Thomas Dean, et al.
Nature Biotechnology
|
June 16, 2014
Backbone modification of a polypeptide drug alters duration of action in vivo
Ross W Cheloha, Akira Maeda, Thomas Dean, et al.
Page
of 5